174 related articles for article (PubMed ID: 32358158)
1. Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry.
Mease PJ; Etzel CJ; Huster WJ; Armstrong AW; Muram TM; Lisse J; Rebello S; Dodge R; Murage MJ; Greenberg JD; Malatestinic WN
J Rheumatol; 2021 Mar; 48(3):376-384. PubMed ID: 32358158
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
J Rheumatol; 2017 Aug; 44(8):1151-1158. PubMed ID: 28620063
[TBL] [Abstract][Full Text] [Related]
3. Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry.
Mease PJ; Etzel CJ; Huster WJ; Muram TM; Armstrong AW; Lisse JR; Rebello S; Dodge R; Murage MJ; Greenberg JD; Malatestinic WN
RMD Open; 2019; 5(1):e000867. PubMed ID: 31245045
[TBL] [Abstract][Full Text] [Related]
4. Association of Nail Psoriasis With Disease Activity Measures and Impact in Psoriatic Arthritis: Data From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Liu M; Rebello S; McLean RR; Dube B; Glynn M; Hur P; Ogdie A
J Rheumatol; 2021 Apr; 48(4):520-526. PubMed ID: 33060307
[TBL] [Abstract][Full Text] [Related]
5. Effect of Multidomain Disease Presentations on Patients With Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Ogdie A; Hur P; Liu M; Rebello S; McLean RR; Dube B; Glynn M; Mease PJ
J Rheumatol; 2021 May; 48(5):698-706. PubMed ID: 33004532
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Men and Women With Axial Spondyloarthritis in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; McLean RR; Dube B; Liu M; Rebello S; Glynn M; Yi E; Park Y; Ogdie A
J Rheumatol; 2021 Oct; 48(10):1528-1536. PubMed ID: 33858974
[TBL] [Abstract][Full Text] [Related]
7. Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Palmer JB; Liu M; Kavanaugh A; Pandurengan R; Ritchlin CT; Karki C; Greenberg JD
J Rheumatol; 2018 Oct; 45(10):1389-1396. PubMed ID: 29961691
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Clinical Diagnosis of Axial Psoriatic Arthritis (PsA) or Elevated Patient-reported Spine Pain in CorEvitas' PsA/Spondyloarthritis Registry.
Ogdie A; Blachley T; Lakin PR; Dube B; McLean RR; Hur P; Mease PJ
J Rheumatol; 2022 Mar; 49(3):281-290. PubMed ID: 34853090
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Certolizumab-Pegol in Rheumatoid Arthritis, Spondyloarthritis, and Psoriatic Arthritis Based on the BIOPURE Registry: Can Early Response Predict Late Outcomes?
Iannone F; Semeraro A; Carlino G; Santo L; Bucci R; Quarta L; Maruotti N; Zuccaro C; Marsico A; Falappone PCF; Mazzotta D; Cantatore FP; Muratore M; Lapadula G
Clin Drug Investig; 2019 Jun; 39(6):565-575. PubMed ID: 30941736
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor.
Ogdie A; Palmer JL; Greenberg J; Curtis JR; Harrold LR; Solomon DH; Kavanaugh A; Kremer JM; Mease PJ
J Rheumatol; 2019 May; 46(5):475-482. PubMed ID: 30647182
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1692-1699. PubMed ID: 28376239
[TBL] [Abstract][Full Text] [Related]
12. High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry.
Fornaro M; Righetti G; Abbruzzese A; Lopalco G; Cacciapaglia F; Anelli MG; Venerito V; Iannone F
Clin Rheumatol; 2021 Sep; 40(9):3659-3665. PubMed ID: 33864158
[TBL] [Abstract][Full Text] [Related]
13. Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real-world Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Liu M; Rebello S; Hua W; McLean RR; Hur P; Ogdie A
J Rheumatol; 2021 Mar; 48(3):367-375. PubMed ID: 32482647
[TBL] [Abstract][Full Text] [Related]
14. Clinical remission in patients with active psoriatic arthritis treated with adalimumab and correlations in joint and skin manifestations.
Van den Bosch F; Kavanaugh A; Kron M; Kupper H; Mease PJ
J Rheumatol; 2015 Jun; 42(6):952-9. PubMed ID: 25834212
[TBL] [Abstract][Full Text] [Related]
15. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
[TBL] [Abstract][Full Text] [Related]
16. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
Lebwohl M; Langley RG; Paul C; Puíg L; Reich K; van de Kerkhof P; Wu HL; Richter S; Jardon S; Gisondi P
Dermatol Ther (Heidelb); 2022 Jan; 12(1):61-78. PubMed ID: 34704231
[TBL] [Abstract][Full Text] [Related]
17. Disease response and patient-reported outcomes among initiators of ixekizumab.
Shahriari M; Harrison RW; Burge R; Lin CY; Malatestinic WN; Goldblum OM; McLean RR; Crabtree MM; O'Brien J; Grace EL; Murage MJ
J Dermatolog Treat; 2022 May; 33(3):1538-1546. PubMed ID: 33267635
[TBL] [Abstract][Full Text] [Related]
18. Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry.
Mease PJ; Palmer JB; Hur P; Strober BE; Lebwohl M; Karki C; Reed GW; Etzel CJ; Greenberg JD; Helliwell PS
J Eur Acad Dermatol Venereol; 2019 May; 33(5):886-892. PubMed ID: 30663130
[TBL] [Abstract][Full Text] [Related]
19. [Association of skin lesion severity with clinical features of psoriatic arthritis].
Liu HL; He N; Dou L; Wang YH; Su JM; Li MT; Leng XM; Zeng XF
Zhonghua Nei Ke Za Zhi; 2022 Jul; 61(7):779-784. PubMed ID: 35764561
[No Abstract] [Full Text] [Related]
20. Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study from the US-based Corrona registry.
Mease PJ; Karki C; Liu M; Li Y; Gershenson B; Feng H; Hur P; Greenberg JD
RMD Open; 2019; 5(1):e000880. PubMed ID: 31168408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
